Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04818866 · ClinicalTrials.gov registry record
International Study of Inflammation in COVID-19
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 4,463
- Enrollment target
NCT04818866 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 4,463 participants.
The verdict
NCT04818866 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 4,463 participants
- Enrollment target
Study Summary
This is a prospective multi-center observational study which purpose is to evaluate the ability of blood-based inflammatory markers to risk-stratify patients hospitalized for Covid-19. Blood-based biomarkers examined include: soluble urokinase plasminogen activator receptor (suPAR), C-reactive protein (CRP), procalcitonin, D-dimer, ferritin, lactate dehydrogenase and interleukin-6.
Interventions
- DIAGNOSTIC_TEST SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,463 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04818866
The ClinicalTrials.gov registry entry for NCT04818866 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,463 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase is the first listed.
NCT04818866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04818866 about?
NCT04818866 is a clinical study titled "International Study of Inflammation in COVID-19". This is a prospective multi-center observational study which purpose is to evaluate the ability of blood-based inflammatory markers to risk-stratify patients hospitalized for Covid-19. Blood-based biomarkers examined include: soluble urokinase plasminogen activator receptor (suPAR), C-reactive prote...
What is the current status of trial NCT04818866?
This trial is currently completed. The enrollment target is 4,463 participants. The study started on 2020-02-01. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT04818866?
The interventions under investigation include: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04818866?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.